These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14735624)

  • 21. Logistical problems of supplying leucodepleted blood components within the national blood service.
    Tandy N
    Transfus Sci; 1998 Dec; 19(4):373-4. PubMed ID: 10351160
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening: In the blood.
    Willyard C
    Nature; 2017 Sep; 549(7673):S19-S21. PubMed ID: 28953860
    [No Abstract]   [Full Text] [Related]  

  • 23. Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease.
    Brown P; Cervenáková L; Diringer H
    J Lab Clin Med; 2001 Jan; 137(1):5-13. PubMed ID: 11150018
    [No Abstract]   [Full Text] [Related]  

  • 24. Validation approaches selective/universal leucodepletion: the need for standardised validation strategies.
    Seghatchian MJ; Krailadsiri P
    Transfus Sci; 1998 Dec; 19(4):363-5. PubMed ID: 10351157
    [No Abstract]   [Full Text] [Related]  

  • 25. Operational and research approaches to universal leucodepletion in Scotland.
    Prowse C
    Transfus Sci; 1998 Dec; 19(4):367-9. PubMed ID: 10351158
    [No Abstract]   [Full Text] [Related]  

  • 26. NBS approaches to the approval of suppliers of leucodepletion systems.
    Smith KJ
    Transfus Sci; 1998 Dec; 19(4):371-2. PubMed ID: 10351159
    [No Abstract]   [Full Text] [Related]  

  • 27. Perspective on Nordic views on selective/universal leukodepletion.
    Flesland O
    Transfus Sci; 1998 Dec; 19(4):355-7. PubMed ID: 10351154
    [No Abstract]   [Full Text] [Related]  

  • 28. Creutzfeldt-Jakob disease.
    Clement P
    Haemophilia; 2000 Jul; 6 Suppl 1():68-78. PubMed ID: 10982271
    [No Abstract]   [Full Text] [Related]  

  • 29. [vCJD epidemiology in France].
    Brandel JP; Salomon D; Alpérovitch A
    Transfus Clin Biol; 2006 Nov; 13(5):304-6. PubMed ID: 17188544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can CJD be transmitted through the blood supply?
    Giulivi A
    CMAJ; 1998 Mar; 158(6):714; author reply 715-7. PubMed ID: 9538847
    [No Abstract]   [Full Text] [Related]  

  • 31. Transfusion-related vCJD: prevention strategies for prion transmission.
    Holland PV
    Lijec Vjesn; 2007 May; 129 Suppl 3():46. PubMed ID: 18959066
    [No Abstract]   [Full Text] [Related]  

  • 32. Can CJD be transmitted through the blood supply.
    Larke B
    CMAJ; 1998 Mar; 158(6):714-5. PubMed ID: 9538848
    [No Abstract]   [Full Text] [Related]  

  • 33. Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure.
    Steinberg D
    J Clin Ethics; 2001; 12(2):134-40. PubMed ID: 11642064
    [No Abstract]   [Full Text] [Related]  

  • 34. The pathophysiology of variant Creutzfeldt-Jacob disease: the hypotheses behind concerns for blood components and products.
    Burthem J; Roberts DJ
    Br J Haematol; 2003 Jul; 122(1):3-9. PubMed ID: 12823340
    [No Abstract]   [Full Text] [Related]  

  • 35. International views on universal leucodepletion: the perspective in NBS, Ireland.
    Murphy W
    Transfus Sci; 1998 Dec; 19(4):349-50. PubMed ID: 10351151
    [No Abstract]   [Full Text] [Related]  

  • 36. Fears grow as blood stocks pass on prions undetected.
    Hopkin M
    Nature; 2004 Aug; 430(7001):712. PubMed ID: 15306772
    [No Abstract]   [Full Text] [Related]  

  • 37. Leukoreduction and blood-borne vCJD transmission risk.
    Douet JY; Bujdoso R; Andréoletti O
    Curr Opin Hematol; 2015 Jan; 22(1):36-40. PubMed ID: 25402620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force.
    Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462
    [No Abstract]   [Full Text] [Related]  

  • 39. Current strategies to prevent transmission of prions by human plasma derivatives.
    Burnouf T; Padilla A
    Transfus Clin Biol; 2006 Nov; 13(5):320-8. PubMed ID: 17254822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New variant Creutzfeldt-Jakob disease: a controversial but potential blood transfusion risk.
    Basu A
    Nepal Med Coll J; 2003 Jun; 5(1):51-2. PubMed ID: 16583978
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.